Taro Reaches Settlement With Shareholders
After failing to get a purported shareholder class action dismissed in March, Taro Pharmaceuticals Ltd. said on Monday that it has reached an agreement with plaintiffs who alleged that the drug...To view the full article, register now.
Already a subscriber? Click here to view full article